Open access · US-GOV via ClinicalTrials.gov Clinical trial

Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial)

Authors not listed

Technische Universität Dresden · 2013

Dysbiosis Human Randomized controlled trial

＋ Sign in to save

Abstract

To study the safety and efficacy of anti-CD20 blockade with ofatumumab in the context of allogeneic HCT in CLL

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-13 MST

Cite this

APA

Anonymous. (2013). Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial). <em>Technische Universität Dresden</em>. https://clinicaltrials.gov/study/NCT01809847

Vancouver

Anonymous. Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial). Technische Universität Dresden. 2013.

BibTeX

@misc{anon2013Ofatum, title = {Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial)}, author = {Anonymous}, journal = {Technische Universität Dresden}, year = {2013}, }